Skip to content

A randomized clinical trial for determining the efficacy of acupressure hand- and foot- reflexology in addition to the anti-epileptic drugs (AEDs) compared with AEDs alone in the management of patients suffering from intractable epilepsy

Randomized clinical trial (RCT) of Reflexology therapy and usual drug treatment in the management of intractable epilepsy

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2010/091/001072
Enrollment
98
Registered
2010-07-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Intractable epilepsy

Interventions

Intervention1: Reflexology therapy of 30 minutes duration twice a day in addition to the anti-epileptic drugs (AEDs): Control Intervention1: Anti-epileptic drugs (AEDs): Pharmacological drugs were as

Sponsors

Central Council for Research in Yoga Naturopathy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of the age group of 3 years to 50 years and both genders had been included if they were the residents of Delhi or had some arrangements to stay in Delhi (the centre of study), for a period of minimum three months, and submitted of their own the filled-in consent proforma. They had been suffering from confirmed epilepsy with at least a frequency of 2 seizures per month, had failed 2 or more drugs in various rational combinations over a period of 2 or more years. They were surgical failures or were not the candidates for surgery. They were likely to stay on the stable and adequate doses of AEDs for a period of 3 months prior to the trial.

Exclusion criteria

Exclusion criteria: Any patient suffering from either or more of the following diseases has been excluded from this study: malignancy of any kind, brain tumor, encephalitis, meningitis, tuberculosis, HIV-infection, and any kind of organ resection due to any reason.

Design outcomes

Primary

MeasureTime frame
1.Response of the patients to the therapy which was measured in terms of improvement in reducing seizure frequency (R) 2.No. of times seizures could be aborted during aura 3.Quality of life in epilepsy Timepoint: 1 year 6 months

Secondary

MeasureTime frame
1.Abnormal features noted on the reflex areas 2.Any other associated symptom Timepoint: 1 year 6 months

Countries

India

Contacts

Public ContactDr Manjari Tripathi

Associate Professor

drkrishnadalal@gmail.com01126593215

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026